CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-01 | Torley Helen President and CEO | Sale | −5,437 | $48.51 | $264K | 470,522 |
| 2021-02-01 | Torley Helen President and CEO | Exercise or conversion · Option to Purchase Common Stock | −50,000 | $14.66 | $733K | 600,000 |
| 2021-01-04 | Kelley Kenneth J Director | Sale | −4,710 | $42.88 | $202K | 195,123 |
| 2021-01-04 | Kelley Kenneth J Director | Sale | −290 | $43.38 | $13K | 194,833 |
| 2020-12-21 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −11,400 | $42.54 | $485K | 123,400 |
| 2020-12-21 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −600 | $43.25 | $26K | 122,800 |
| 2020-12-07 | Kelley Kenneth J Director | Sale | −35,086 | $41.00 | $1.4M | 199,833 |
| 2020-12-02 | Kelley Kenneth J Director | Sale | −31,792 | $41.00 | $1.3M | 234,919 |
| 2020-11-30 | Torley Helen President and CEO | Gift | −10,000 | 470,522 | ||
| 2020-11-27 | Kelley Kenneth J Director | Sale | −10,000 | $41.25 | $413K | 266,711 |
| 2020-11-25 | Kelley Kenneth J Director | Sale | −9,671 | $41.50 | $401K | 276,711 |
| 2020-11-25 | Henderson Jeffrey William Director | Sale | −24,498 | $40.08 | $982K | 47,609 |
| 2020-11-25 | Daly James M Director | Sale | −10,363 | $40.41 | $419K | 21,002 |
| 2020-11-25 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 530,522 |
| 2020-11-25 | Torley Helen President and CEO | Sale | −22,326 | $40.17 | $897K | 508,196 |
| 2020-11-25 | Torley Helen President and CEO | Sale | −27,674 | $41.18 | $1.1M | 480,522 |
| 2020-11-25 | Torley Helen President and CEO | Exercise or conversion · Option to Purchase Common Stock | −50,000 | $14.66 | $733K | 650,000 |
| 2020-11-20 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −4,111 | $38.24 | $157K | 142,689 |
| 2020-11-20 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −7,889 | $39.04 | $308K | 134,800 |
| 2020-10-20 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −12,000 | $30.43 | $365K | 146,800 |
Page 54 of 59 · 1,177 trades